Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor

被引：38

作者：

Zhou, Li ^{[1
]}

You, Jian-Hua ^{[1
]}

Wu, Wen ^{[1
]}

Li, Jun-Min ^{[1
]}

Shen, Zhi-Xiang ^{[1
]}

Wang, Ai-Hua ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol, Ruijin Hosp,Dept Hematol, Shanghai 200025, Peoples R China

来源：

LEUKEMIA RESEARCH | 2013年 / 37卷 / 10期

关键词：

Imatinib; Nilotinib; Chronic myeloid leukemia; Pregnancy; OF-THE-LITERATURE; IMATINIB MESYLATE; C-KIT; THERAPY; PDGFR; RAT;

D O I：

10.1016/j.leukres.2013.07.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We presented our experience in chronic myeloid leukemia (CML) patients who conceived children and/or became pregnant while receiving tyrosine kinase inhibitor (TKI). Among 7 male patients, 7 pregnancies resulted in the birth of 7 healthy babies. Among 18 female patients, 8 ended in elective abortion; 3 had spontaneous abortion, and 7 carried to term, resulting in the birth of 8 healthy babies. All children have normal growth and development. All patients remain in TKI therapy and in good response. It is suggested that female patients are advised to practice adequate contraception. No special precautions apply for male patients receiving TKI. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：1216 / 1221

页数：6

共 50 条

[1] Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor
Ono, Takaaki
Takahashi, Naoto
Kizaki, Masahiro
Kawaguchi, Tatsuya
Suzuki, Ritsuro
Yamamoto, Kazuhito
Ohnishi, Kazunori
Naoe, Tomoki
Matsumura, Itaru
[J]. CANCER SCIENCE, 2020, 111 (10) : 3714 - 3725
[2] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
Mario Tiribelli
Ahmet Emre Eskazan
[J]. Oncology and Therapy, 2019, 7 : 95 - 100
[3] Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
Tiribelli, Mario
Eskazan, Ahmet Emre
[J]. ONCOLOGY AND THERAPY, 2019, 7 (02) : 95 - 100
[4] Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Castillo, Dan Ran
Park, Daniel
Mehta, Akhil
Kaur, Simmer
Nguyen, Anthony
Akhtari, Mojtaba
[J]. HEMATOLOGY REPORTS, 2022, 14 (01) : 45 - 53
[5] PREGNANCIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH TYSOSINE KINASE INHIBITORS
Wang, A.
Zhou, L.
[J]. HAEMATOLOGICA, 2013, 98 : 555 - 555
[6] Second Tyrosine Kinase Inhibitor Discontinuation Attempt in Patients With Chronic Myeloid Leukemia
Legros, Laurence
Nicolini, Franck E.
Etienne, Gabriel
Rousselot, Philippe
Rea, Delphine
Giraudier, Stephane
Guerci-Bresler, Agnes
Huguet, Francoise
Gardembas, Martine
Escoffre, Martine
Ianotto, Jean-Christophe
Noel, Marie-Pierre
Varet, Bruno R.
Pagliardini, Thomas
Touitou, Irit
Morisset, Stephane
Mahon, Francois-Xavier
[J]. CANCER, 2017, 123 (22) : 4403 - 4410
[7] Tyrosine Kinase Inhibitor Dosing Patterns in Elderly Patients With Chronic Myeloid Leukemia
Seo, Hee Yeon
Ko, Tae Hwa
Hyun, Shin Young
Song, Hyebin
Lim, Seung Taek
Shim, Kwang Yong
Lee, Jong In
Kong, Jee Hyun
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11): : 735 - +
[8] Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy
D J DeAngelo
[J]. Blood Cancer Journal, 2012, 2 : e95 - e95
[9] Adherence to tyrosine kinase inhibitor and clinical outcomes in patients with chronic myeloid leukemia
Cheng, Fang
Cui, Zheng
Li, Qiang
Wang, Liu
Li, Weiming
[J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
[10] Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy
DeAngelo, D. J.
[J]. BLOOD CANCER JOURNAL, 2012, 2 : e95 - e95

← 1 2 3 4 5 →